Church & Dwight (NYSE:CHD) Given “Sector Perform” Rating at Royal Bank of Canada

Royal Bank of Canada reissued their sector perform rating on shares of Church & Dwight (NYSE:CHD) in a research report released on Monday morning,Benzinga reports. Royal Bank of Canada currently has a $105.00 price target on the stock.

A number of other analysts have also issued reports on the stock. JPMorgan Chase & Co. lifted their price target on shares of Church & Dwight from $99.00 to $107.00 and gave the stock an “underweight” rating in a research note on Thursday, January 16th. Stifel Nicolaus cut their target price on shares of Church & Dwight from $105.00 to $103.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. Piper Sandler decreased their price target on Church & Dwight from $128.00 to $126.00 and set an “overweight” rating for the company in a research note on Monday. Deutsche Bank Aktiengesellschaft upped their price objective on Church & Dwight from $114.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Finally, Wells Fargo & Company boosted their price target on Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $111.00.

Church & Dwight Price Performance

CHD opened at $106.37 on Monday. Church & Dwight has a twelve month low of $96.09 and a twelve month high of $113.50. The firm has a market cap of $26.06 billion, a price-to-earnings ratio of 44.88, a PEG ratio of 3.28 and a beta of 0.59. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.51. The company has a fifty day simple moving average of $106.30 and a 200 day simple moving average of $104.22.

Church & Dwight (NYSE:CHD) last announced its earnings results on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same quarter last year, the business earned $0.65 EPS. Equities research analysts expect that Church & Dwight will post 3.7 EPS for the current fiscal year.

Church & Dwight Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Friday, February 14th will be issued a $0.295 dividend. This represents a $1.18 dividend on an annualized basis and a yield of 1.11%. This is an increase from Church & Dwight’s previous quarterly dividend of $0.28. The ex-dividend date is Friday, February 14th. Church & Dwight’s dividend payout ratio is presently 47.68%.

Insider Activity

In other Church & Dwight news, CEO Matthew Farrell sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $103.84, for a total value of $31,152,000.00. Following the completion of the transaction, the chief executive officer now directly owns 112,719 shares in the company, valued at $11,704,740.96. This trade represents a 72.69 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Bradley C. Irwin sold 13,200 shares of Church & Dwight stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $107.44, for a total transaction of $1,418,208.00. Following the completion of the transaction, the director now directly owns 37,169 shares in the company, valued at approximately $3,993,437.36. This trade represents a 26.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 415,622 shares of company stock valued at $43,994,559 over the last three months. Insiders own 1.40% of the company’s stock.

Institutional Trading of Church & Dwight

Several hedge funds and other institutional investors have recently modified their holdings of CHD. Empowered Funds LLC lifted its position in shares of Church & Dwight by 2.8% in the 3rd quarter. Empowered Funds LLC now owns 3,651 shares of the company’s stock worth $382,000 after acquiring an additional 99 shares during the period. Oppenheimer & Co. Inc. lifted its position in Church & Dwight by 0.3% in the third quarter. Oppenheimer & Co. Inc. now owns 32,066 shares of the company’s stock worth $3,358,000 after purchasing an additional 104 shares during the period. HCR Wealth Advisors boosted its stake in Church & Dwight by 0.9% during the fourth quarter. HCR Wealth Advisors now owns 11,754 shares of the company’s stock worth $1,231,000 after buying an additional 106 shares in the last quarter. Kingsview Wealth Management LLC increased its holdings in Church & Dwight by 3.3% in the 3rd quarter. Kingsview Wealth Management LLC now owns 3,373 shares of the company’s stock valued at $353,000 after buying an additional 107 shares during the period. Finally, Atria Wealth Solutions Inc. raised its stake in shares of Church & Dwight by 0.9% in the 4th quarter. Atria Wealth Solutions Inc. now owns 12,124 shares of the company’s stock valued at $1,270,000 after buying an additional 110 shares in the last quarter. Institutional investors and hedge funds own 86.60% of the company’s stock.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.